Cardiovascular risk in Hashimoto thyroiditis patients according to their thyroid state: a cross-sectional study

Cardiovascular risk in Hashimoto thyroiditis patients according to their thyroid state: a cross-sectional study

dc.creatorGómez, Karina
dc.creatorCéspedes, Yasmin
dc.creatorRodríguez, Emily
dc.date2023-03-11
dc.date.accessioned2023-09-05T21:36:46Z
dc.date.available2023-09-05T21:36:46Z
dc.identifierhttps://revistas.intec.edu.do/index.php/cisa/article/view/2768
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8678201
dc.descriptionAims: To investigate the association between cardiovascular risk factors and cardiovascular risk score with the thyroid status of patients with Hashimoto’s Thyroiditis. Methods: Thirty-eight consenting adults with Hashimoto’s Thyroiditis participated in this cross-sectional study. The cardiovascular risk factors considered included age, sex, blood pressure, body mass index, fast blood glucose, lipid profile, cardiovascular comorbidities, C reactive protein, and erythrocyte sedimentation rate. The Framingham CV risk score was performed. The sample was classified into euthyroid (n = 15), clinical hypothyroidism (n = 9), and subclinical hypothyroidism (n = 13), and included the presence of antithyroid antibodies. Fisher’s exact test was used to determine the association between the variables studied. Results: 100% of the sample were women; a mean age between 39-59 years old. The category with low risk was the largest (n = 30), equivalent to 78.9%; moderate risk, no patient was obtained; high risk (n = 8) constituted 21.1%. Statistical significance between age and CV risk score in patients with clinical hypothyroidism was found (p < 1), 95% CI. The glucose level in the subclinical hypothyroidism and clinical hypothyroidism had statistical significance. The presence of anti-Thyroglobulin (antiTg) was shown to be closely related to the level of CV risk in patients with subclinical hypothyroidism. Conclusion: Age, glycemia, anti-Tg, history of DM, dyslipidemia, or cerebrovascular accidents have been linked to raising the risk of developing CVD in up to 10 years depending on their thyroid profile. No evidence of a direct relationship between CV risk score and thyroid state was found in the participants of this study.en-US
dc.descriptionAims: To investigate the association between cardiovascular risk factors and cardiovascular risk score with the thyroid status of patients with Hashimoto’s Thyroiditis. Methods: Thirty-eight consenting adults with Hashimoto’s Thyroiditis participated in this cross-sectional study. The cardiovascular risk factors considered included age, sex, blood pressure, body mass index, fast blood glucose, lipid profile, cardiovascular comorbidities, C reactive protein, and erythrocyte sedimentation rate. The Framingham CV risk score was performed. The sample was classified into euthyroid (n = 15), clinical hypothyroidism (n = 9), and subclinical hypothyroidism (n = 13), and included the presence of antithyroid antibodies. Fisher’s exact test was used to determine the association between the variables studied. Results: 100% of the sample were women; a mean age between 39-59 years old. The category with low risk was the largest (n = 30), equivalent to 78.9%; moderate risk, no patient was obtained; high risk (n = 8) constituted 21.1%. Statistical significance between age and CV risk score in patients with clinical hypothyroidism was found (p < 1), 95% CI. The glucose level in the subclinical hypothyroidism and clinical hypothyroidism had statistical significance. The presence of anti-Thyroglobulin (antiTg) was shown to be closely related to the level of CV risk in patients with subclinical hypothyroidism. Conclusion: Age, glycemia, anti-Tg, history of DM, dyslipidemia, or cerebrovascular accidents have been linked to raising the risk of developing CVD in up to 10 years depending on their thyroid profile. No evidence of a direct relationship between CV risk score and thyroid state was found in the participants of this study.es-ES
dc.formatapplication/pdf
dc.formattext/html
dc.languagespa
dc.publisherIntituto Tecnológico de Santo Domingo (INTEC)es-ES
dc.relationhttps://revistas.intec.edu.do/index.php/cisa/article/view/2768/3212
dc.relationhttps://revistas.intec.edu.do/index.php/cisa/article/view/2768/3213
dc.rightsDerechos de autor 2023 Ciencia y Saludes-ES
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0es-ES
dc.sourceScience and Health; Vol. 7 No. 1 (2023): Science and Health, january-march; 7-15en-US
dc.sourceCiencia y Salud; Vol. 7 Núm. 1 (2023): Ciencia y Salud, enero-marzo; 7-15es-ES
dc.source2613-8824
dc.source2613-8816
dc.source10.22206/cysa.2023.v7i1
dc.subjectautoimmune thyroiditisen-US
dc.subjectHashimoto's diseaseen-US
dc.subjectcardiovascular diseasesen-US
dc.subjectrisk factor'sen-US
dc.subjectautoimmune thyroiditises-ES
dc.subjectHashimoto's diseasees-ES
dc.subjectcardiovascular diseaseses-ES
dc.subjectrisk factor'ses-ES
dc.titleCardiovascular risk in Hashimoto thyroiditis patients according to their thyroid state: a cross-sectional studyen-US
dc.titleCardiovascular risk in Hashimoto thyroiditis patients according to their thyroid state: a cross-sectional studyes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución